Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Photo, Video

16:30 New photos show mother right after giving birth in car, says it was 'perfect'

113

Health

All category news

  • Switching IV fluids could save thousands of lives, researchers say

    February 28, 2018 10:21 PM 40

    This medication was manufactured by the Quaker Bitters company around 1900. Apparently, it had all kinds of uses: "A stomach tonic. For nervousness, catarrh of the head and stomach, scrofulous humor, canker, pimples and humors on the face, summer complaints, female weaknesses. Restores the appetite, purifies the blood. For dyspepsia, constipation, sick headache

  • Mylan teams up with Revance on biosimilar for Botox

    February 28, 2018 9:28 PM 52

    NEW YORK (Reuters) - Mylan NV on Wednesday struck a licensing agreement with Revance Therapeutics Inc to develop a biosimilar of Allergan Plc’s blockbuster Botox wrinkle treatment. The deal includes an upfront payment of $25 million to Revance​, Mylan said. Revance’s own rival to Botox is not yet approved by the U.S. Food and Drug Administration. Revance

  • Roche says hemophilia drug Hemlibra wins EU approval

    February 27, 2018 4:49 PM 39

    ZURICH (Reuters) - Swiss group Roche said on Tuesday the European Commission has approved its drug Hemlibra for people with hemophilia A who have developed resistance to standard treatments. The approval was expected after a panel recommended it last month. The drug was already approved in the United States last year. Hemlibra is among the new medicines

  • Tourist infected with measles went to New York art museum, area hotels, health officials say

    February 25, 2018 1:28 PM 83

    An Australian tourist infected with measles visited several locations in New York City, included the famed Metropolitan Museum of Art, before seeking treatment, health officials warned Saturday. The New York State Department of Health said in a news release the sightseer was visiting between Feb. 16 and Feb. 21 and stayed at several hotels in the greater-New

  • Novo Nordisk gets nod from U.S. drug purchaser for new diabetes hope

    February 21, 2018 4:59 PM 47

    COPENHAGEN (Reuters) - Insulin maker Novo Nordisk said its Ozempic diabetes drug had been included on a list of medicines approved for patients covered by U.S. private health schemes, setting the stage for a battle with Eli Lilly’s Trulicity. Novo Nordisk, the world’s biggest insulin maker, launched Ozempic, known generically as semaglutide, in the United

  • Aimmune's peanut allergy drug meets main goal of key study

    February 20, 2018 12:53 PM 42

    (Reuters) - U.S. drug developer Aimmune Therapeutics Inc said on Tuesday its peanut allergy drug met the main goal of an eagerly awaited late-stage study. The company said 67.2 percent of patients administered AR101 aged between 4–17 tolerated at least a 600-mg dose of peanut protein in the exit food challenge, compared to 4.0 percent of patients on placebo

  • Make-a-Wish grants leukemia patient her dream of having a backyard pirate ship

    February 19, 2018 9:35 PM 39

    The Make-a-Wish Foundation made a little girl's seafaring dreams come true, gifting five-year-old Leona Evans her very own backyard pirate ship. Evans is a leukemia patient and often can't play at public playgrounds during treatment because of her delicate immune system. Now she can combine her two favorite things, playing outside and playing pirates

  • Autistic boy gets birthday surprise from 'Army guys' he 'idolizes'

    February 19, 2018 9:15 PM 36

    Half a dozen members of the army stepped up to make an autistic boy's ninth birthday one he'll never forget. A boy with autism who loves the military had a special birthday visit from a few men in fatigues. A group of soldiers from the U.S. Army surprised 9-year-old Riley at his Sacramento area home for his birthday. His mother, Jessica Upchurch, told Fox 40, “He wanted

  • U.S. FDA approves AstraZeneca's immunotherapy for lung cancer

    February 16, 2018 10:22 PM 45

    (Reuters) - The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc‘s, immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can’t be surgically removed. The approval was based on a trial testing on 713 patients whose cancer had not progressed after chemotherapy and radiation

  • Brazil yellow fever vaccine campaign struggling to meet goal

    February 15, 2018 10:13 PM 102

    Brazil's Health Ministry says a massive yellow fever vaccination campaign has reached less than 20 percent of the targeted population since it began three weeks ago. Authorities have confirmed 407 cases in the current outbreak, including in areas not previously considered at risk. Of those, 118 have died. The campaign aims to vaccinate more than 20 million